Larry Tiffany is an experienced Chief Executive Officer with a strong background in the medical device industry.

He holds a Master's degree in Biotechnology from The Johns Hopkins University and has expertise in Pharmaceutics, Good Laboratory Practice (GLP), Medical Devices, Oncology, and Molecular Biology.

Larry Tiffany has served in key roles in various organizations including as CEO and Director at Medcura (formerly gel-e, Inc.), Director Board Of Directors at TGM Medicine, CEO at DioGenix, and GM Genomics at Gene Logic.